[PDF] Top 20 CD4 T-Helper Responses to the Anaplastic Lymphoma Kinase (ALK) Protein in Patients with ALK-Positive Anaplastic Large-Cell Lymphoma
Has 10000 "CD4 T-Helper Responses to the Anaplastic Lymphoma Kinase (ALK) Protein in Patients with ALK-Positive Anaplastic Large-Cell Lymphoma" found on our website. Below are the top 20 most common "CD4 T-Helper Responses to the Anaplastic Lymphoma Kinase (ALK) Protein in Patients with ALK-Positive Anaplastic Large-Cell Lymphoma".
CD4 T-Helper Responses to the Anaplastic Lymphoma Kinase (ALK) Protein in Patients with ALK-Positive Anaplastic Large-Cell Lymphoma
... CTL responses to anaplastic lymphoma kinase (ALK) in patients with ALK- positive anaplastic large-cell lymphoma ... Voir le document complet
5
Correlation of the autoantibody response to the ALK oncoantigen in pediatric anaplastic lymphoma kinase–positive anaplastic large cell lymphoma with tumor dissemination and relapse risk
... of the importance of the immune system in cancer development and ...1,2 Anaplastic lymphoma kinase (ALK)-positive anaplastic large cell ... Voir le document complet
6
Anaplastic lymphoma kinase is a dependence receptor whose proapoptotic functions are activated by caspase cleavage.: Dual effects of ALK on apoptosis : a new dependence receptor
... ABSTRACT ALK (anaplastic lymphoma kinase) is a receptor tyrosine kinase, initially discovered as part of the NPM-ALK fusion protein, resulting from the t(2 ... Voir le document complet
53
Circulating Antibodies to ALK Inversely Correlat with Relapse Risk and Circulating Tumor Cells in Children and Adolescents with ALK-Positive Anaplastic Large Cell Lymphoma
... antibodies to ALK were detected in 80/86 (93%) of patients ...studied. The titers ranged between 1/50 and ≥1/60750. The median follow-up of the patients was ... Voir le document complet
4
B and CTL responses to the ALK protein in patients with ALK-positive ALCL
... compared to ALK-nega- tive ALCL, possibly as a result of the immune recognition of the ALK ...proteins. The aim of our study was to investigate the pres- ence of ... Voir le document complet
8
Migration Properties Distinguish Tumor Cells of Classical Hodgkin Lymphoma from Anaplastic Large Cell Lymphoma Cells
... found in the Supplementary Methods section (Supplementary File ...]. The antibodies used, their providers, and the dilutions used are provided in the Supplementary ...11), ... Voir le document complet
17
CD4-positive T-helper cell responses to the PASD1 protein in patients with diffuse large B-cell lymphoma
... months) Patients previously reported in the description of a CTL response to ...diffuse large B-cell lymphoma; DLBCL(t): diffuse large B-cell lymphoma ... Voir le document complet
9
ALK (anaplastic lymphoma kinase, CD246)-specific CARs: new immunotherapeutic agents for the treatment of pediatric solid tumors
... 2013 The identification of unique cell-surface proteins expressed on tumor cells, yet not expressed on normal tissues, has been challenging for pediatric ...malignancies. The cell sur- face ... Voir le document complet
2
Description of Two Cases of Anaplastic Large Cell Lymphoma Associated with a Breast Implant
... under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly ...implant-associated ... Voir le document complet
7
Predictive value of PET response combined with baseline metabolic tumor volume in peripheral T-cell lymphoma patients
... T-cell lymphoma (PTCL) encompasses a heteroge- neous and rare group of aggressive lymphomas derived from postthymic T ...subtypes with characteristic nodal involvement, are the most frequent ... Voir le document complet
8
Sp17 Protein Expression and Major Histocompatibility Class I and II Epitope Presentation in Diffuse Large B Cell Lymphoma Patients
... under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly ...for patients with ... Voir le document complet
10
Increased activation of PI3 kinase-δ predisposes to B cell lymphoma.
... The clinical features and severity of APDS1 and APDS2 vary greatly from one patient to another - even within the same family 14,15 .... Patients present with recurrent bacterial and ... Voir le document complet
17
Cytolytic T-cell response to the PASD1 cancer testis antigenin patients with diffuse large B-cell lymphoma
... Summary The identification of immunogenic cancer testis antigens (CTAs) as immunotherapeutic targets represents one approach to improve treatment options for diffuse large B-cell ... Voir le document complet
12
Evidence for IL-35 Expression in Diffuse Large B-Cell Lymphoma and Impact on the Patient's Prognosis
... of the IL-12 family consisting of two subunits, EBV-induced gene 3 (EBI3) and ...shown to play a pro-tumor role in murine tumor models, and in various types of human cancer such as colorectal, ... Voir le document complet
13
Prognostic value of FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET Project
... In contrast to previous reported findings in other lymphoma entities 3 , no prognostic value of MTV measured on the whole-body was found for PFS or OS (data not ...calculated in ... Voir le document complet
20
BMP7 Expression Correlates with Secondary Drug Resistance in Mantle Cell Lymphoma
... as the ratio between the expression after therapy and at ...patient, the paired sample (before treatment and at relapse/progression) was co-hybridized on Agilent dual color DNA ...chips. The ... Voir le document complet
10
Results from the Belgian mantle cell lymphoma registry
... summarized in Table 1 . The median age at diagnosis was 64 years (range 23–96 ...displayed in Fig. 1 . We compared the results of the total group of patients with ... Voir le document complet
8
Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter retrospective study from Lymphoma Study Association (LYSA) centers
... ANGLAIS: The combination of carmustine, etoposide, cytarabine, and melphalan (BEAM) as conditioning regimen prior to autologous stem -cell transplantation (ASCT) remains the standard of care ... Voir le document complet
49
The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab.
... only in patients receiving chemotherapy associated with ...of cell of origin signature in R-CHOP patients Wright et al established a predictor for Germinal Center (GC) and ... Voir le document complet
23
Stromal cell contribution to human follicular lymphoma pathogenesis.
... REMARKS In vitro and in vivo studies corroborate the hypothesis that lym- phoid BM and LN stromal cells play a central role in the devel- opment, growth, progression, and drug ... Voir le document complet
8
Sujets connexes